On Oct. 4, 2023, ASTHO responded to a Request for Information from the U.S. House of Representatives' Ways and Means Committee on the subject of improving access to healthcare and rural and underserved areas, including the island ...
I think we all welcomed 2021 with open arms as we look to put the worst of 2020 behind us. We have all been through a lot—we have lost family members and friends to COVID-19, we have seen public health officials harassed and maligned, we ...
On March 29, 2023, ASTHO submitted comments in response to the Senate's request for information during their deliberations to reauthorize the Pandemic and All-Hazards Preparedness Act.
Advocating on Capitol Hill for strong public health systems is critical to advancing the work of state and territorial health agencies. ASTHO's 2019 “Washington Week” has come and gone, but the work is far from over.
ASTHO CEO Michael Fraser looks back on nine of the top public health highlights in 2019.
ASTHO CEO Michael Fraser's Testimony in Regards to the U.S. Department of Health and Human Services for the Committee on Appropriations, United States Senate
On Oct. 20, 2023, ASTHO submitted a response to a Request for Information from the U.S. Senate's Health, Education, Labor, and Pensions Committee on the modernization of CDC.
On July 10, 2023, ASTHO submitted comments on the Senate Health, Education, Labor, and Pensions bipartisan discussion draft to reauthorize the Pandemic and All-Hazards Preparedness Act.
In January 2024, ASTHO sent a letter to President Biden asking for the administration's support in adopting and implementing a federal rule to prohibit the sale of menthol flavored combustible cigarettes.